Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

ANZUPGO (Delgocitinib): A New Era in Moderate-to-Severe Chronic Hand Eczema Treatment (Article)

Summary by dermatologytimes.com
Dermatology Times connects dermatology professionals with key skin disorder coverage, therapeutic strategies, clinical trial updates, and expert insights.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

dermatologytimes.comdermatologytimes.com

ANZUPGO (delgocitinib): A New Era in Moderate-to-Severe Chronic Hand Eczema Treatment (Article)

Dermatology Times connects dermatology professionals with key skin disorder coverage, therapeutic strategies, clinical trial updates, and expert insights.

Read Full Article
The Medical RepublicThe Medical Republic

JAKi effective for teen hand eczema - Medical Republic

Presented at ISAD 2025 in Melbourne, the phase 3 findings strengthen evidence for the non-steroidal cream delgocitinib across age groups.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Medical Republic broke the news in on Monday, November 3, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Australia icon

Australia

News
For You
SearchBlindspotLocal